Glassman Wealth Services »

Vir Biotechnology shares owned by Glassman Wealth Services

Quarter-by-quarter ownership of Vir Biotechnology (VIR) shares owned by Glassman Wealth Services from 13F filings

Historical chart of Glassman Wealth Services investment in Vir Biotechnology

Tip: Access up to 7 years of quarterly data

All positions including Vir Biotechnology held by Glassman Wealth Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vir Biotechnology by Glassman Wealth Services

Quarter filed Position value Share count Share price at filing
2023-12-31 $292 29 10.07
2023-09-30 $5.3k 565 9.37
2022-03-31 $0 1 0.00

More positions owned by Glassman Wealth Services

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Schwab Strategic Tr Schwab Fdt Us Lg (FNDX)
Wisdomtree Tr Us Qtly Div Grt (DGRW)
Vanguard Intl Equity Index F Allwrld Ex Us (VEU)
Dimensional Etf Trust World Ex Us Core (DFAX)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Ishares Tr Rus 1000 Etf (IWB)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Mun Bd Fds Tax Exempt Bd (VTEB)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Schwab Strategic Tr Us Lcap Va Etf (SCHV)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core S&p Mcp Etf (IJH)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)

View all positions for Glassman Wealth Services

Top funds holding Vir Biotechnology

Vanguard Group
Baillie Gifford & Co
Citadel Advisors
Alliancebernstein
Bill & Melinda Gates Foundation
Bank of New York Mellon
D. E. Shaw & Co
Charles Schwab Investment Management
Goldman Sachs Group
Voloridge Investment Management
UBS Group
Dimensional Fund Advisors
Principal Financial Group
Barclays
Millennium Management

View all funds holding Vir Biotechnology